These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35636572)

  • 1. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
    Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Hua L; Wei M; Feng C; Li S; Wen X; Chen S
    Cancer Biother Radiopharm; 2024 Jun; ():. PubMed ID: 38828494
    [No Abstract]   [Full Text] [Related]  

  • 5. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
    Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
    Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
    Comput Biol Med; 2024 Jul; 177():108593. PubMed ID: 38801795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
    Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
    Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
    Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
    Kou L; Zhang T; Yang X; Peng S; Wang Y; Yuan M; Li M
    Future Oncol; 2022 May; 18(16):1917-1915. PubMed ID: 35193379
    [No Abstract]   [Full Text] [Related]  

  • 11. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
    Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
    Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
    J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Value of Adjuvant Chemotherapy after Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Wang YN; Zhong ML; Liang MR; Yang JT; Zeng SY
    Gynecol Obstet Invest; 2023; 88(5):286-293. PubMed ID: 37497957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of outcome using pretreatment
    Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
    Wang SX; Yang Y; Xie H; Yang X; Liu ZQ; Li HJ; Huang WJ; Luo WJ; Lei YM; Sun Y; Ma J; Chen YF; Liu LZ; Mao YP
    Eur Radiol; 2024 Oct; 34(10):6831-6842. PubMed ID: 38514481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
    Laliscia C; Gadducci A; Mattioni R; Orlandi F; Giusti S; Barcellini A; Gabelloni M; Morganti R; Neri E; Paiar F
    Tumori; 2022 Aug; 108(4):376-385. PubMed ID: 34235995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
    Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
    Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer.
    Ai Y; Zhu X; Zhang Y; Li W; Li H; Zhao Z; Zhang J; Ning B; Li C; Zheng Q; Zhang J; Jin J; Li Y; Xie C; Jin X
    Radiother Oncol; 2024 Aug; 197():110328. PubMed ID: 38761884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
    Shen H; Yin J; Niu R; Lian Y; Huang Y; Tu C; Liu D; Wang X; Lan X; Yuan X; Zhang J
    Radiother Oncol; 2022 Jun; 171():107-113. PubMed ID: 35461950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.